Back to series
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Markus Wallner, MD, PhD, FESC, FAHA, FHFA
Sign up and create your MedShr account in order to start this learning module
MedShr

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction

Markus Wallner, MD, PhD, FESC, FAHA, FHFA
Expected time taken: 20 mins

Late Breaking Clinical Trial - Presented at #ESC HF 2022

Sign up to start learning
,